Kintara Therapeutics (KTRA) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.95
-1.32
-0.68
-0.05

Details

Expected EPS
-0.25
Actual EPS
-0.05
Surprise EPS
0.2
Surprise Percent
+80%

Description

Kintara Therapeutics (KTRA) has reported earnings of -0.05 per share for Q2 2024.

0 Comments

Share your thoughts